SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-14-003654
Filing Date
2014-11-12
Accepted
2014-11-12 16:02:26
Documents
10
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT form10q.htm 10-Q 679946
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 16822
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 16783
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 8377
  Complete submission text file 0001493152-14-003654.txt   5653265

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE immy-20140930.xml EX-101.INS 781720
6 XBRL SCHEMA FILE immy-20140930.xsd EX-101.SCH 60999
7 XBRL CALCULATION FILE immy-20140930_cal.xml EX-101.CAL 77264
8 XBRL DEFINITION FILE immy-20140930_def.xml EX-101.DEF 190512
9 XBRL LABEL FILE immy-20140930_lab.xml EX-101.LAB 420735
10 XBRL PRESENTATION FILE immy-20140930_pre.xml EX-101.PRE 293991
Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35814 | Film No.: 141213900
SIC: 2834 Pharmaceutical Preparations